FR2224140A1 - Polyvinyl pyrrolidone veterinary compns - for internal or external treatment of gastrointestinal inflammatory and gynaecological conditions - Google Patents
Polyvinyl pyrrolidone veterinary compns - for internal or external treatment of gastrointestinal inflammatory and gynaecological conditionsInfo
- Publication number
- FR2224140A1 FR2224140A1 FR7312255A FR7312255A FR2224140A1 FR 2224140 A1 FR2224140 A1 FR 2224140A1 FR 7312255 A FR7312255 A FR 7312255A FR 7312255 A FR7312255 A FR 7312255A FR 2224140 A1 FR2224140 A1 FR 2224140A1
- Authority
- FR
- France
- Prior art keywords
- veterinary
- compns
- internal
- polyvinyl pyrrolidone
- external treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000002496 gastric effect Effects 0.000 title abstract 2
- 230000002757 inflammatory effect Effects 0.000 title abstract 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 title 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 title 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 239000003463 adsorbent Substances 0.000 abstract 1
- 230000000172 allergic effect Effects 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 230000002421 anti-septic effect Effects 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 229940064004 antiseptic throat preparations Drugs 0.000 abstract 1
- -1 antiseptics Substances 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 239000003224 coccidiostatic agent Substances 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 150000003456 sulfonamides Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
- 108700012359 toxins Proteins 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
- A61K31/79—Polymers of vinyl pyrrolidone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Therapeutic compsns. comprising as active component polyvinylpolyprrolidone (I) optionally together with coccidiostats, sulphonamides, antiseptics, antibiotics, adsorbents and vitamines are useful in veterinary treatment of gastrointestinal, inflammatory and gynaecological conditions, internally or externally; (I) are insoluble in acids and alkalis, non-allergic and non-toxic, and adsorb toxins in their three-dimensional network allowing tissues to regenerate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7312255A FR2224140A1 (en) | 1973-04-05 | 1973-04-05 | Polyvinyl pyrrolidone veterinary compns - for internal or external treatment of gastrointestinal inflammatory and gynaecological conditions |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7312255A FR2224140A1 (en) | 1973-04-05 | 1973-04-05 | Polyvinyl pyrrolidone veterinary compns - for internal or external treatment of gastrointestinal inflammatory and gynaecological conditions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2224140A1 true FR2224140A1 (en) | 1974-10-31 |
| FR2224140B1 FR2224140B1 (en) | 1976-04-09 |
Family
ID=9117453
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7312255A Granted FR2224140A1 (en) | 1973-04-05 | 1973-04-05 | Polyvinyl pyrrolidone veterinary compns - for internal or external treatment of gastrointestinal inflammatory and gynaecological conditions |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2224140A1 (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2414917A1 (en) * | 1978-01-24 | 1979-08-17 | Schiapparelli Spa | Syrups contg. gentamycin and kaolin - for gastrointestinal infections, stabilised by reducing the metal content of the kaolin |
| US4210633A (en) * | 1978-10-20 | 1980-07-01 | Eli Lilly And Company | Flurandrenolide film formulation |
| US4289749A (en) * | 1979-08-14 | 1981-09-15 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing phenylpropanolamine |
| US4291014A (en) * | 1979-01-11 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing estradiol diacetate |
| EP0035142A3 (en) * | 1980-02-22 | 1982-06-23 | BASF Aktiengesellschaft | Utilisation of micronized, crosslinked insoluble polyvinylpyrrolidone for the stabilisation of suspensions |
| EP2186521A1 (en) * | 2008-11-14 | 2010-05-19 | Mergemeier Steffen | Compositons for the treatment and prevention of diseases involving bacterial, viral and fungal pathogens and fragments thereof with polyvinylpyrrolidone and/or polyvinylpolypyrrolidone as therapeutically active compound |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4906475A (en) | 1988-02-16 | 1990-03-06 | Paco Pharmaceutical Services | Estradiol transdermal delivery system |
-
1973
- 1973-04-05 FR FR7312255A patent/FR2224140A1/en active Granted
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2414917A1 (en) * | 1978-01-24 | 1979-08-17 | Schiapparelli Spa | Syrups contg. gentamycin and kaolin - for gastrointestinal infections, stabilised by reducing the metal content of the kaolin |
| US4210633A (en) * | 1978-10-20 | 1980-07-01 | Eli Lilly And Company | Flurandrenolide film formulation |
| US4291014A (en) * | 1979-01-11 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing estradiol diacetate |
| US4289749A (en) * | 1979-08-14 | 1981-09-15 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing phenylpropanolamine |
| US4291015A (en) * | 1979-08-14 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing a vasodilator |
| US4292303A (en) * | 1979-08-14 | 1981-09-29 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing clonidine |
| US4292301A (en) * | 1979-08-14 | 1981-09-29 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing ephedrine |
| US4292302A (en) * | 1979-08-14 | 1981-09-29 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing terbutaline |
| US4294820A (en) * | 1979-08-14 | 1981-10-13 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing phenylephrine |
| EP0035142A3 (en) * | 1980-02-22 | 1982-06-23 | BASF Aktiengesellschaft | Utilisation of micronized, crosslinked insoluble polyvinylpyrrolidone for the stabilisation of suspensions |
| EP2186521A1 (en) * | 2008-11-14 | 2010-05-19 | Mergemeier Steffen | Compositons for the treatment and prevention of diseases involving bacterial, viral and fungal pathogens and fragments thereof with polyvinylpyrrolidone and/or polyvinylpolypyrrolidone as therapeutically active compound |
| WO2010054858A3 (en) * | 2008-11-14 | 2010-08-19 | Steffen Mergemeier | Polyvinylpyrrolidone as a therapeutically active compound for the treatment and prevention of diseases involving bacterial, viral and fungal pathogens |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2224140B1 (en) | 1976-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1030319A (en) | Surgical dressings | |
| EP0142426A3 (en) | Ophthalmic formulation containing norfloxacin and related antibiotics | |
| AU465226B2 (en) | Anthelmintically active benximidazole derivatives and processes for preparing them | |
| ES2151607T3 (en) | GROWTH AND DIFFERENTIATION FACTOR 12. | |
| FR2224140A1 (en) | Polyvinyl pyrrolidone veterinary compns - for internal or external treatment of gastrointestinal inflammatory and gynaecological conditions | |
| IE40860L (en) | N- heterocyclylalkylbenzamides | |
| CA982739A (en) | Polyamide imides and polyamic acid precursors | |
| SE9201930D0 (en) | GASTRIC ANTIBACTERIAL TREATMENT | |
| IL41709A0 (en) | N-(aminomethylidene)-thiol-phosphoric acid ester imides,their manufacture and their use as insecticides and acaricides | |
| IT956328B (en) | POROUS BODY RIGIDED AT THE EDGES PROCEDURE AND DEVICE FOR THE PRODUCTION OF THE SAME | |
| CA989307A (en) | Agent for the treatment of hyperlipoproteinemias and process for the preparation thereof | |
| IE811449L (en) | Pyrrolidine derivatives. | |
| TR17151A (en) | DISUBSTITUEE N- (AMINOMETYLIDEN) -TIOL (TIONO) PHOSPHORIC ACID ESTER IMIDES, PROCEDURES SPECIFIC TO ITS PRODUCTS AND INSECTICIDES AND THEIR USE AS MISCIDES | |
| CA815315A (en) | Veterinary and medical vaginal treatment instrument | |
| SU628904A1 (en) | Anesthesia method | |
| CA810173A (en) | Treatment and composition for high blood pressure and palpitation | |
| CA868341A (en) | Biologically active decapeptides and process for their preparation | |
| CA989836A (en) | Substituted axazino (5,6,e) indole, its manufacturing process and therapeutic application | |
| AU150656B2 (en) | Improvements in or relating to medical treatment chambers | |
| Langohr et al. | Bacteriologic study of burn wounds; the incidence, virulence and resistance to penicillin of the staphylococcus in burn wounds of patients treated with penicillin or sulfonamides; the significance of staphylococcal immunity to the healing of the wounds infected with the staphylococcus | |
| CA954045A (en) | Treatment of mastitis in cows, the product for this treatment and to the production of said product | |
| AU3475171A (en) | Method for producing of articles from hydrophilic polymers appropriate for repeated or longterm contact with living tissue or mucous membrane | |
| RU96110874A (en) | METHOD FOR TREATING CHLAMIDIOSIS IN WOMEN WITH INFERTILITY OF TUBE-PERITONEAL AND TUBE-ENDOCRINE GENESIS | |
| CA949352A (en) | Blood pressure cuff | |
| BE790707A (en) | REMEDY AGAINST DISEASES OF THE PERIPHERAL ARTERIAL SYSTEM, CONTUSIONS, FROSTBELLS, WOUNDS ATONES AND SCLERODERMIA IN |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |